|
1
|
Hernigou P, Beaujean F and Lambotte JC:
Decrease in the mesenchymal stem-cell pool in the proximal femur in
corticosteroid-induced osteonecrosis. J Bone Joint Surg Br.
81:349–355. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernigou P and Beaujean F: Abnormalities
in the bone marrow of the iliac crest in patients who have
osteonecrosis secondary to corticosteroid therapy or alcohol abuse.
J Bone Joint Surg Am. 79:1047–1053. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang JK, Ho ML, Yeh CH, Chen CH and Wang
GJ: Osteogenic gene expression decreases in stromal cells of
patients with osteonecrosis. Clin Orthop Relat Res. 453:286–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JS, Lee JS, Roh HL, Kim CH, Jung JS
and Suh KT: Alterations in the differentiation ability of
mesenchymal stem cells in patients with nontraumatic osteonecrosis
of the femoral head: Comparative analysis according to the risk
factor. J Orthop Res. 24:604–609. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cárcamo-Orive II, Gaztelumendi A, Delgado
J, Tejados N, Dorronsoro A, Fernández-Rueda J, Pennington DJ and
Trigueros C: Regulation of human bone marrow stromal cell
proliferation and differentiation capacity by glucocorticoid
receptor and AP-1 crosstalk. J Bone Miner Res. 25:2115–2125. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rauch A, Seitz S, Baschant U, Schilling
AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A,
Schmidt-Ullrich R, et al: Glucocorticoids suppress bone formation
by attenuating osteoblast differentiation via the monomeric
glucocorticoid receptor. Cell Metab. 11:517–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gangaraju VK and Lin H: MicroRNAs: Key
regulators of stem cells. Nat Rev Mol Cell Biol. 10:116–125. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lakshmipathy U and Hart RP: Concise
review: MicroRNA expression in multipotent mesenchymal stromal
cells. Stem Cells. 26:356–363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li T, Li H, Li T, Fan J, Zhao RC and Weng
X: MicroRNA expression profile of dexamethasone-induced human bone
marrow-derived mesenchymal stem cells during osteogenic
differentiation. J Cell Biochem. 115:1683–1691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li T, Li H, Wang Y, Li T, Fan J, Xiao K,
Zhao RC and Weng X: microRNA-23a inhibits osteogenic
differentiation of human bone marrow-derived mesenchymal stem cells
by targeting LRP5. Int J Biochem Cell Biol. 72:55–62. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tong P, Wu C, Jin H, Mao Q, Yu N, Holz JD,
Shan L, Liu H and Xiao L: Gene expression profile of
steroid-induced necrosis of femoral head of rats. Calcif Tissue
Int. 89:271–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto T, Irisa T, Sugioka Y and Sueishi
K: Effects of pulse methylprednisolone on bone and marrow tissues:
Corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum.
40:2055–2064. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bao L, Zhao J, Dai X, Wang Y, Ma R, Su Y,
Cui H, Niu J, Bai S, Xiao Z, et al: Correlation between miR-23a and
onset of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol.
38:318–330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mengru C, Masahiro S, Chie S, Hideaki M,
Kazuhiro K, Yuji M, Rintaro N, Akinobu Y, Li C and Akihiko G:
MiR-23a regulates TGF-es TGF- Yuji M, Rintaro N, Akinobu Y, Li C
and Akihiko G: MiR-23a regulates TGF-s TGF-y 38: 318–323, 2014.
Oncology. 41:869–875. 2012.
|
|
15
|
Jahid S, Sun J, Edwards RA, Dizon D,
Panarelli NC, Milsom JW, Sikandar SS, Gümüs ZH and Lipkin SM:
miR-23a promotes the transition from indolent to invasive
colorectal cancer. Cancer Discov. 2:540–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin ST, Huang Y, Zhang L, Heng MY, Ptácek
LJ and Fu YH: MicroRNA-23a promotes myelination in the central
nervous system. Proc Natl Acad Sci USA. 110:pp. 17468–17473. 2013;
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seeliger C, Karpinski K, Haug AT, Vester
H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating
miRNAs and bone tissue miRNAs are associated with osteoporotic
fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui Y, Niziolek PJ, MacDonald BT, Zylstra
CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon
RA, et al: Lrp5 functions in bone to regulate bone mass. Nat Med.
17:684–691. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yadav VK, Ryu JH, Suda N, Tanaka KF,
Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna
KL, et al: Lrp5 controls bone formation by inhibiting serotonin
synthesis in the duodenum. Cell. 135:825–837. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu X, Zhang Y, Guo X, Xu H, Xu Z, Duan D
and Wang K: Identification of differentially expressed microRNAs
involved in non-traumatic osteonecrosis through microRNA expression
profiling. Gene. 565:22–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Qian W, Wu Z, Bian Y and Weng X:
Preliminary screening of differentially expressed circulating
microRNAs in patients with steroid-induced osteonecrosis of the
femoral head. Mol Med Rep. 10:3118–3124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamasaki K, Nakasa T, Miyaki S, Yamasaki
T, Yasunaga Y and Ochi M: Angiogenic microRNA-210 is present in
cells surrounding osteonecrosis. J Orthop Res. 30:1263–1270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu
X, Feng Y and Dai Z: MiR-17-5p modulates osteoblastic
differentiation and cell proliferation by targeting SMAD7 in
non-traumatic osteonecrosis. Exp Mol Med. 46:e1072014. View Article : Google Scholar : PubMed/NCBI
|
